Presently, close to 140 companies claim to be actively engaged in offering patient recruitment / ret

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, close to 140 companies are actively offering patient recruitment and retention services. Majority of these players possess vast service portfolios and utilize diverse patient outreach methods to recruit study participants across different geographies and therapeutic indications.

To order this 300+ page report, which features 90+ figures and 140+ tables, please visit this –

The USD 5.3 billion (by 2030) financial opportunity within the patient recruitment and retention services market has been analyzed across the following segments:
 Therapeutic Area
 Oncology
 Infectious Diseases
 Cardiovascular Diseases
 CNS Disorders
 Respiratory Disorders
 Metabolic Disorders
 Others

 Steps in Patient Recruitment Process
 Pre-screening
 Screening

 Phase of Development
 Phase I
 Phase II
 Phase III
 Phase IV

 Key Geographical Region
 North America
 Europe
 Asia-Pacific
 Rest of the world

The Patient Recruitment and Retention Services Marker, 2019-2030.” report features the following companies, which we identified to be key players in this domain:
 Acurian
 BBK Worldwide
 Bright Pharmaceuticals Services
 ClinEdge
 CSSi
 Ignite Data
 Integrated Clinical Trial Services
 Pacific Groove
 Polaris BioPharma Consulting
 Topstone Research
 TrialWire
 Tudor Reilly Health
 WCCT Global

Table of Contents

1. Preface

2. Executive Summary

3. Patient Recruitment and Retention In Clinical Trials

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415  

Leave a Reply

Your email address will not be published. Required fields are marked *